Literature DB >> 25556445

MiR-323-5p acts as a tumor suppressor by targeting the insulin-like growth factor 1 receptor in human glioma cells.

Hai-Wei Lian1, Yun Zhou, Zhi-Hong Jian, Ren-Zhong Liu.   

Abstract

BACKGROUND: MicroRNAs, small noncoding RNA molecules, can regulate mammalian cell growth, apoptosis and differentiation by controlling the expression of target genes. The aim of this study was to investigate the function of miR-323-5p in the glioma cell line, U251.
MATERIALS AND METHODS: After over-expression of miR-323- 5p using miR-323-5p mimics, cell growth, apoptosis and migration were tested by MTT, flow cytometry and cell wound healing assay, respectively. We also assessed the influence of miR-323-5p on the mRNA expression of IGF- 1R by quantitative real-time reverse transcriptase PCR (qRT-PCR), and on the protein levels by Western blot analysi. In addition, dual-luciferase reporter assays were performed to determine the target site of miR-323-5p to IGF-1R 3'UTR.
RESULTS: Our findings showed that over-expression of miR-323-5p could promote apoptosis of U251 and inhibit the proliferation and migration of the glioma cells.
CONCLUSIONS: This study demonstrated that increased expression of miR-323-5p might be related to glioma progression, which indicates a potential role of miR-323-5p for clinical therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556445     DOI: 10.7314/apjcp.2014.15.23.10181

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

Review 1.  Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Authors:  Padacherri Vethil Jishnu; Pradyumna Jayaram; Vaibhav Shukla; Vinay Koshy Varghese; Deeksha Pandey; Krishna Sharan; Sanjiban Chakrabarty; Kapaettu Satyamoorthy; Shama Prasada Kabekkodu
Journal:  Clin Exp Metastasis       Date:  2019-12-07       Impact factor: 5.150

2.  Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Authors:  Tal Shahar; Avital Granit; Daniel Zrihan; Tamar Canello; Hanna Charbit; Ofira Einstein; Uri Rozovski; Sharona Elgavish; Zvi Ram; Tali Siegal; Iris Lavon
Journal:  J Neurooncol       Date:  2016-08-29       Impact factor: 4.130

3.  Novel sphingomyelin biomarkers for brain glioma and associated regulation research on the PI3K/Akt signaling pathway.

Authors:  Xiao-Hui Zhai; Jian Xiao; Jie-Kai Yu; Hong Sun; Shu Zheng
Journal:  Oncol Lett       Date:  2019-10-02       Impact factor: 2.967

4.  A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer.

Authors:  James Saller; Kun Jiang; Yin Xiong; Sean J Yoder; Kevin Neill; Jose M Pimiento; Luis Pena; F Scott Corbett; Anthony Magliocco; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2021-03-13       Impact factor: 3.199

5.  MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.

Authors:  Wenyao Wang; Hongfei Zhang; Mao Tang; Longlong Liu; Zhengfang Zhou; Shaojun Zhang; Lichao Wang
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

6.  MicroRNA-323a-3p Negatively Regulates NEK6 in Colon Adenocarcinoma Cells.

Authors:  Zhongshi Hong; Zhichuan Chen; Jianpeng Pan; Zesheng Shi; Chunxiao Wang; Chengzhi Qiu
Journal:  J Oncol       Date:  2022-01-19       Impact factor: 4.375

7.  Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.

Authors:  Gang Deng; Ronghao Wang; Yin Sun; Chi-Ping Huang; Shuyuan Yeh; Bosen You; Changyong Feng; Gonghui Li; Shenglin Ma; Chawnshang Chang
Journal:  Cell Death Differ       Date:  2021-06-14       Impact factor: 15.828

8.  MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.

Authors:  Yao Xiao; Qinggang Tian; Jiantai He; Ming Huang; Chao Yang; Liansheng Gong
Journal:  Onco Targets Ther       Date:  2016-06-15       Impact factor: 4.147

Review 9.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.